Product Description
Description: Ceftorque T 1.125 Dry Injection is a medication combining Ceftriaxone and Tazobactam is used in the treatment of the bacterial infection.
Pharmaceutical Dosage Form: Dry Injection
Route of Administration: Injection
Composition: Each Vail contains:
Ceftriaxone Sodium (Sterile)
Eq. to Anhydrous Ceftriaxone I.P. 1000 mg
Tazobactum Sodium (Sterile)
Eq. to Anhydrous Tazobactum I.P. 125 mg
Mechanism of Action: Ceftriaxone belongs to the class of antibiotics that works by interfering with the formation of the bacterial cell wall (a protective covering) necessary for their survival. Thereby damaging the bacterial cell wall and killing bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.
Indications: Ceftorque T 1.125 is used to treat Respiratory Tract infection, Intra-Abdominal Infection, Urinary Tract Infection, Septicemia, Meningitis.
Dosage: As prescribed by the physician.
Storage: Store protected from light and moisture at a temperature not exceeding 250
Presentation: 12 x 20 x 10ml
Side effects:
Nausea
Headache
Dizziness
Abdominal pain
Diarrhea
Contraindications: Ceftorque T 1.125 is contraindicated in patients with a history of hypersensitivity to the beta-lactum antibiotics.
